SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029297
Filing Date
2018-11-13
Accepted
2018-11-13 16:02:26
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fixx-10q_20180930.htm 10-Q 2083363
2 EX-10.1 fixx-ex101_190.htm EX-10.1 16550
3 EX-31.1 fixx-ex311_6.htm EX-31.1 16545
4 EX-31.2 fixx-ex312_9.htm EX-31.2 18431
5 EX-32.1 fixx-ex321_8.htm EX-32.1 9681
6 EX-32.2 fixx-ex322_7.htm EX-32.2 9935
  Complete submission text file 0001564590-18-029297.txt   7309003

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fixx-20180930.xml EX-101.INS 1644531
8 XBRL TAXONOMY EXTENSION SCHEMA fixx-20180930.xsd EX-101.SCH 51317
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fixx-20180930_cal.xml EX-101.CAL 42728
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fixx-20180930_def.xml EX-101.DEF 177705
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20180930_lab.xml EX-101.LAB 372588
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20180930_pre.xml EX-101.PRE 281260
Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 181177862
SIC: 2834 Pharmaceutical Preparations